Antiviral treatment of influenza in South Korea

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Review of Anti-Infective Therapy

• Publication date

  2015-05-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14787210.2015.1032253PMID 25835433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region - an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases

  2015cited by this paper
• The challenges of global case reporting during pandemic A(H1N1) 2009.

  2014cited by this paper
• A review of neuraminidase inhibitor susceptibility in influenza strains

  2014cited by this paper
• Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

  2014cited by this paper
• Combination Effects of Peramivir and Favipiravir against Oseltamivir-Resistant 2009 Pandemic Influenza A(H1N1) Infection in Mice

  2014cited by this paper
• Severe influenza treatment guideline

  2014cited by this paper
• Epidemiology of Pathogen-Specific Respiratory Infections among Three US Populations

  2014cited by this paper
• Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

  2014cited by this paper
• Antivirals for influenza: a summary of a systematic review and meta‐analysis of observational studies

  2013cited by this paper
• A Comparison of the Clinical and Epidemiological Characteristics of Adult Patients with Laboratory-Confirmed Influenza A or B during the 2011–2012 Influenza Season in Korea: A Multi-Center Study

  2013cited by this paper
• Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis

  2013cited by this paper
• Socioeconomic Burden of Influenza in the Republic of Korea, 2007–2010

  2013cited by this paper
• Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010

  2013cited by this paper
• Socioeconomic Burden of Influenza in the Republic of Korea, 2007–2010

  2013cited by this paper
• Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons

  2013cited by this paper
• Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days

  2012cited by this paper
• Epidemiological and Virological Characteristics of Influenza in the Western Pacific Region of the World Health Organization, 2006–2010

  2012cited by this paper
• Clinical Practice Guideline for Antiviral Treatment and Chemoprophylaxis of Seasonal Influenza

  2012cited by this paper
• Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

  2012cited by this paper
• High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005–2010

  2012cited by this paper
• Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.

  2012cited by this paper
• Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk Patients

  2011cited by this paper
• Oseltamivir Prescription and Regulatory Actions Vis-à-Vis Abnormal Behavior Risk in Japan: Drug Utilization Study Using a Nationwide Pharmacy Database

  2011influential reference
• Trends in Pneumonia and Influenza-associated Hospitalizations in South Korea, 2002-2005

  2011cited by this paper
• Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.

  2011cited by this paper
• Modeling for Estimating Influenza Patients from ILI Surveillance Data in Korea

  2011cited by this paper
• First Fatal Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Case in an Adult in Korea

  2011cited by this paper
• The Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season

  2011cited by this paper
• Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2011cited by this paper
• Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico

  2011cited by this paper
• Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus Infection

  2011cited by this paper
• Triple-Combination Antiviral Drug for Pandemic H1N1 Influenza Virus Infection in Critically Ill Patients on Mechanical Ventilation

  2011cited by this paper
• Successful salvage therapy with inhaled zanamivir in a patient with peramivir-resistant pandemic influenza A (H1N1) 2009 virus

  2011cited by this paper
• Drug-Resistant Pandemic (H1N1) 2009, South Korea

  2011cited by this paper
• A Fatal Case in Pregnant Woman Infected by H1N1 2009 in Korea

  2011cited by this paper
• Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea

  2010cited by this paper
• [National level response to pandemic (H1N1) 2009].

  2010cited by this paper
• Oseltamivir efficacy, side effects, and safety in children with influenza

  2010cited by this paper
• Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.

  2009cited by this paper
• Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.

  2009cited by this paper
• A Case of Acute Pulmonary Thromboembolism Complicated Pandemic Influenza (H1N1 2009)

  2009cited by this paper
• A Case of Oseltamivir-Resistant Pandemic Influenza (H1N1 2009)

  2009cited by this paper
• Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08

  2009cited by this paper
• The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.

  2009cited by this paper
• Emergence of Amantadine-Resistant H3N2 Avian Influenza A Virus in South Korea

  2008cited by this paper
• Amantadine and Zanamivir Resistance of Influenza A/H3N2 Viruses Isolated in Korea, 2002/03~2003/04

  2008cited by this paper
• Influenza surveillance in Korea: establishment and first results of an epidemiological and virological surveillance scheme

  2007cited by this paper
• Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors

  2006cited by this paper
• Potential Impact of Antiviral Drug Use during Influenza Pandemic

  2005cited by this paper
• Zanamivir: an influenza virus neuraminidase inhibitor

  2005cited by this paper
• Amantadine and rimantadine for preventing and treating influenza A in adults.

  2004cited by this paper
• Safety and Pharmacology of Oseltamivir in Clinical Use

  2003cited by this paper
• Of Interest

  2002cited by this paper
• Neuraminidase Inhibitors: Zanamivir and Oseltamivir

  2001cited by this paper
• Influenza virus neuraminidase inhibitors.

  2000cited by this paper

• Increased use of third‐generation cephalosporin antibiotics in the outpatient setting in Korean children and adolescents

  2018cites this paper
• Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea

  2018cites this paper
• Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study

  2018cites this paper